Albarq Drug Industries Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 08-12-2024
- Paid Up Capital ₹ 0.20 M
as on 08-12-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About Albarq Drug Industries
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Rameez Beigh, Rauf Beigh, Masrat Beigh, and Two other members serve as directors at the Company.
- CIN/LLPIN
U36999JK2017PTC010055
- Company No.
010055
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jammu
Industry
Company Details
- Location
Srinagar, Jammu & Kashmir, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Albarq Drug Industries?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rameez Beigh  | Director | 26-Jul-2017 | Current |
| Rauf Beigh | Director | 26-Jul-2017 | Current |
| Masrat Beigh | Director | 26-Jul-2017 | Current |
| Rahat Beigh | Director | 26-Jul-2017 | Current |
| Ahlam Mushtaq | Director | 21-Apr-2019 | Current |
Financial Performance of Albarq Drug Industries.
Albarq Drug Industries Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Albarq Drug Industries?
Unlock access to Albarq Drug Industries's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Albarq Global Services Private LimitedActive 3 years 4 monthsRameez Beigh, Rauf Beigh and 1 more are mutual person
- Albarq Agro Industries Private LimitedActive 1 year 5 months
Rameez Beigh, Rauf Beigh and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Albarq Drug Industries?
Unlock and access historical data on people associated with Albarq Drug Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Albarq Drug Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Albarq Drug Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.